Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Camiel Goulooze

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2024
Time-varying covariates, overadjustment bias and mediation in pharmacokinetic/pharmacodynamic modelingSebastiaan Camiel Goulooze, Nelleke Snelder
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2026
Tutorial on Causal Mediation Analysis for PharmacometriciansSebastiaan Camiel Goulooze, Eleonora Marostica, Nelleke Snelder
CPT: Pharmacometrics & Systems Pharmacology|March 12, 2026
Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event DataSebastiaan Camiel Goulooze, Nelleke Snelder, Thomas Eissing, et al.
Clinical Pharmacokinetics|May 4, 2022
Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKDSebastiaan Camiel Goulooze, Hiddo J L Heerspink, Martijn van Noort, et al.
Clinical Pharmacokinetics|November 17, 2021
Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion CriteriaSebastiaan Camiel Goulooze, Nelleke Snelder, Andreas Seelmann, et al.
Diabetes, Obesity & Metabolism|December 1, 2023
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKDThomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|July 16, 2024
Time-varying covariates, overadjustment bias and mediation in pharmacokinetic/pharmacodynamic modelingSebastiaan Camiel Goulooze, Nelleke Snelder
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2026
Tutorial on Causal Mediation Analysis for PharmacometriciansSebastiaan Camiel Goulooze, Eleonora Marostica, Nelleke Snelder
CPT: Pharmacometrics & Systems Pharmacology|March 12, 2026
Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event DataSebastiaan Camiel Goulooze, Nelleke Snelder, Thomas Eissing, et al.
Clinical Pharmacokinetics|May 4, 2022
Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKDSebastiaan Camiel Goulooze, Hiddo J L Heerspink, Martijn van Noort, et al.
Clinical Pharmacokinetics|November 17, 2021
Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion CriteriaSebastiaan Camiel Goulooze, Nelleke Snelder, Andreas Seelmann, et al.
Diabetes, Obesity & Metabolism|December 1, 2023
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKDThomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, et al.
Pageof 1